(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

RECEPTORES DE ANTÍGENOS QUIMÉRICOS DE DUPLO DIRECIONAMENTO

Em AnáliseInvention PatentPCT · US2021057407

Application data

Number

112023008280

Type

Invention Patent

Filing

10/29/2021

Publication

06/06/2023

PCT

US2021057407

Progress at the INPI

  1. Filing10/29/21
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 10/29/2021. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 06/06/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL

US

See this company's full portfolio

Inventors

G. D. (pessoa física)

US

H. D. (pessoa física)

US

K. H. (pessoa física)

JP

Y. X. (pessoa física)

CN

Technical data

Priority claims

US

63/108,047 · 10/30/2020

Abstract

RECEPTORES DE ANTÍGENOS QUIMÉRICOS DE DUPLO DIRECIONAMENTO.A presente invenção refere-se a uma terapia de células T do receptor de antígeno quimérico para o tratamento de pacientes com câncer, como um câncer tendo um ou mais tumores sólidos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

06/06/2023

RPI 2735

Alteração de dados cadastrais

#1.1

05/09/2023

RPI 2731

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.